AstraZeneca PLC (AZN)
182.58
-2.34
(-1.27%)
USD |
NYSE |
May 07, 16:00
182.00
-0.58
(-0.32%)
After-Hours: 20:00
AstraZeneca EPS Diluted (Quarterly) : 0.9849 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GSK Plc | 1.149 |
| Amgen, Inc. | 3.344 |
| Biogen, Inc. | 2.153 |
| Gilead Sciences, Inc. | 1.742 |
| Moderna, Inc. | -3.40 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.076B |
| Revenue (Quarterly) | 15.26B |
| Total Expenses (Quarterly) | 12.19B |
| Enterprise Value | 313.07B |
| Gross Profit Margin (Quarterly) | 76.09% |
| Profit Margin (Quarterly) | 20.15% |
| Earnings Yield | 1.82% |
| Operating Earnings Yield | 2.46% |
| Normalized Earnings Yield | 1.845 |